Doxorubicin-based neoadjuvant chemotherapy is associated with Poorer Five-Year Survival in patients with locally advanced breast cancer: A retrospective single-center study in Indonesia

Nuraini Oktaviani, Bambang Sutrisna, Sonar Soni Panigoro, Dina Dwi Mulia, Megawati, Erwin Yulian

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Doxorubicin-based neoadjuvant chemotherapy is associated with Poorer Five-Year Survival in patients with locally advanced breast cancer: A retrospective single-center study in Indonesia'. Together they form a unique fingerprint.

Medicine & Life Sciences